OTOF (Otoferlin) variants and mutations
OTOF (also known as Otoferlin) is a human protein-coding gene encoding an otoferlin protein. It couples calcium entry to synaptic-vesicle fusion at inner hair-cell ribbon synapses, enabling rapid transmission of acoustic signals to the auditory nerve. Biallelic loss-of-function variants cause DFNB9 auditory neuropathy or nonsyndromic sensorineural hearing loss. This analysis covers 2,968 OTOF variants and mutations. Of these, 78% have computational variant effect predictions. Disease context includes autosomal recessive nonsyndromic hearing loss 9, hearing loss, autosomal recessive, and deafness. Example OTOF variants include A2T, A2V, and L3F.
Variant analysis overview
- Gene: OTOF
- Protein: Otoferlin
- UniProt accession: Q9HC10
- Organism: Homo sapiens
- Variants analyzed: 2968
- Variant scope: all variants
- Completed: 2026-08-18
Variant and mutation evidence
- Variant composition: 2,711 unspecified-consequence records; 3 stop lost; 130 missense variants; 90 synonymous variants; 11 frameshift variants; 6 stop-gained variants; 7 in-frame deletions; 1 stop retained variant; 2 in-frame insertions; 3 splice-region variants; 4 substitution
- Prediction scores: 2,302 variants have prediction scores (78% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: autosomal recessive nonsyndromic hearing loss 9, hearing loss, autosomal recessive, deafness, nonsyndromic genetic hearing loss, auditory neuropathy, Rare genetic deafness, Sensorineural hearing impairment, Hearing impairment, tricho-oculo-dermo-vertebral syndrome, Abnormality of the ear, hereditary disease, ear malformation.
Protein structure and variant hotspots
- Protein features: 1 transmembrane segments; 7 domains; 19 binding sites.
- Structural context: 1,298 variants have structural context.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, AlphaFold DB, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.
Notable OTOF variants
Examples include A2T, A2V, L3F, L3S, L4F, I5F, I5M, I5V. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- A2T (p.Ala2Thr), cosmic curated COSV55517, Ensembl rs2148144262, REVEL 0.51, CADD 23.70
- A2V (p.Ala2Val), Ensembl rs1667654756
- L3F (p.Leu3Phe), ExAC rs779861554, gnomAD rs779861554, REVEL 0.31, CADD 22.80, Likely benign
- L3S (p.Leu3Ser), Ensembl rs2148144254
- L4F (p.Leu4Phe), ExAC rs758195578, TOPMed rs758195578, gnomAD rs758195578, REVEL 0.14, CADD 14.60
- I5F (p.Ile5Phe), ExAC rs745503114, gnomAD rs745503114, REVEL 0.30, CADD 21.80, Uncertain significance
- I5M (p.Ile5Met), ExAC rs779470519, TOPMed rs779470519, gnomAD rs779470519
- I5V (p.Ile5Val), rs745503114, ClinGen CA346106857, ClinVar RCV002266190, ExAC rs745503114, REVEL 0.18, CADD 10.90, Uncertain significance, not specified
- H6P (p.His6Pro), Ensembl rs1572507204
- H6Y (p.His6Tyr), TOPMed rs1456419643, gnomAD rs1456419643, REVEL 0.37, CADD 18.20
- L7F (p.Leu7Phe), rs757533828, NCI-TCGA Cosmic COSV5550, cosmic curated COSV55502, ExAC rs757533828, REVEL 0.41, CADD 23.50, Variant assessed as somatic; moderate impact.
- K8R (p.Lys8Arg), TOPMed rs1667653941, gnomAD rs1667653941, REVEL 0.15, CADD 20.70
- T9A (p.Thr9Ala), cosmic curated COSV55512, ExAC rs764457788, TOPMed rs764457788, gnomAD rs764457788, REVEL 0.34, CADD 22.10
- T9I (p.Thr9Ile), TOPMed rs1429859500, gnomAD rs1429859500, REVEL 0.41, CADD 23.50
- T9P (p.Thr9Pro), ExAC rs764457788, TOPMed rs764457788, gnomAD rs764457788, REVEL 0.51, CADD 25.30
- S11* (p.Ser11Ter), rs200972155, ClinGen CA1564847, ClinVar RCV002536735, ClinVar RCV005633674, CADD 36.00, Pathogenic
- S11L (p.Ser11Leu), rs200972155, ClinGen CA1564846, cosmic curated COSV55501, ClinVar RCV001575943, REVEL 0.14, CADD 17.80, Conflicting interpretations, not provided
- R14L (p.Arg14Leu), rs200279237, ClinGen CA346106606, ClinVar RCV002748651, AlphaMissense 0.10, MetaLR 0.37, Uncertain significance, Inborn genetic diseases
- R14Q (p.Arg14Gln), rs200279237, NCI-TCGA Cosmic COSV5552, cosmic curated COSV55522, TOPMed rs200279237, REVEL 0.23, AlphaMissense 0.10, Uncertain significance, not provided
- R14W (p.Arg14Trp), rs774530840, ClinGen CA1564844, NCI-TCGA Cosmic COSV5550, cosmic curated COSV55502, REVEL 0.65, CADD 26.10, Uncertain significance, Inborn genetic diseases
- G15D (p.Gly15Asp), ESP rs370677816, ExAC rs370677816, TOPMed rs370677816, gnomAD rs370677816, REVEL 0.44, CADD 22.30
- R16K (p.Arg16Lys), Ensembl rs1667653029
- D18H (p.Asp18His), ESP rs376856990, ExAC rs376856990, TOPMed rs376856990, gnomAD rs376856990, REVEL 0.59, CADD 24.50, Likely benign
- D18N (p.Asp18Asn), rs376856990, ClinGen CA1564842, ClinVar RCV002946287, ClinVar RCV003561131, REVEL 0.24, CADD 23.00, Conflicting interpretations, Inborn genetic diseases; not provided
- R19Q (p.Arg19Gln), 1000Genomes rs200316189, ESP rs200316189, ExAC rs200316189, TOPMed rs200316189, REVEL 0.41, CADD 26.80
- R19W (p.Arg19Trp), rs727504985, ClinGen CA184765, ClinVar RCV000156400, ClinVar RCV002510796, REVEL 0.68, CADD 27.90, Conflicting interpretations, Inborn genetic diseases; not specified; not provided
- I20T (p.Ile20Thr), Ensembl rs1667652608
- A21T (p.Ala21Thr), rs778670384, ClinGen CA1564838, cosmic curated COSV55504, ClinVar RCV000785040, REVEL 0.32, CADD 24.50, Uncertain significance, Autosomal recessive nonsyndromic hearing loss 9; Inborn genetic diseases
- A21V (p.Ala21Val), rs2148144145, ClinGen CA346106430, ClinVar RCV001788855, NCI-TCGA TCGA novel, REVEL 0.18, CADD 24.50, Benign, Autosomal recessive nonsyndromic hearing loss 9
- K22E (p.Lys22Glu), Ensembl rs1667652478
- V23A (p.Val23Ala), TOPMed rs1572507104, gnomAD rs1572507104, REVEL 0.47, CADD 26.30
- V23G (p.Val23Gly), TOPMed rs1572507104, gnomAD rs1572507104
- V23L (p.Val23Leu), NCI-TCGA Cosmic COSV9971, cosmic curated COSV99718, Variant assessed as somatic; moderate impact.
- T24I (p.Thr24Ile), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- R26* (p.Arg26Ter), rs145208539, ClinGen CA1564837, ClinVar RCV001922354, ClinVar RCV003120739, CADD 43.00, Pathogenic
- R26G (p.Arg26Gly), ESP rs145208539, ExAC rs145208539, TOPMed rs145208539, gnomAD rs145208539, Pathogenic
- R26L (p.Arg26Leu), rs749555751, NCI-TCGA Cosmic COSV5549, NCI-TCGA Cosmic COSV9971, cosmic curated COSV99718, REVEL 0.40, CADD 25.60, Variant assessed as somatic; moderate impact.
- R26Q (p.Arg26Gln), cosmic curated COSV55497, ExAC rs749555751, TOPMed rs749555751, gnomAD rs749555751, REVEL 0.35, CADD 25.40
- G27E (p.Gly27Glu), rs778056468, ClinGen CA1564818, cosmic curated COSV55500, ClinVar RCV000214397, REVEL 0.44, CADD 25.30, Uncertain significance, not specified
- G27R (p.Gly27Arg), NCI-TCGA Cosmic COSV5549, cosmic curated COSV55494, Variant assessed as somatic; moderate impact.
- Q28* (p.Gln28Ter), 1000Genomes rs770168563, ExAC rs770168563, gnomAD rs770168563, CADD 42.00
- Q28K (p.Gln28Lys), 1000Genomes rs770168563, ExAC rs770168563, gnomAD rs770168563, REVEL 0.07, CADD 19.60
- S29F (p.Ser29Phe), Ensembl rs1310213812, REVEL 0.44, CADD 24.50
- F30L (p.Phe30Leu), ExAC rs781632684, TOPMed rs781632684, gnomAD rs781632684, REVEL 0.36, CADD 25.40
- Y31C (p.Tyr31Cys), gnomAD rs1158246186, REVEL 0.42, CADD 26.10
- S32P (p.Ser32Pro), ExAC rs755070380, TOPMed rs755070380, gnomAD rs755070380, REVEL 0.57, CADD 26.90
- S32T (p.Ser32Thr), ExAC rs755070380, TOPMed rs755070380, gnomAD rs755070380, REVEL 0.20, CADD 22.60
- S32Y (p.Ser32Tyr), NCI-TCGA TCGA novel, REVEL 0.53, CADD 26.10, Variant assessed as somatic; moderate impact.
- R33P (p.Arg33Pro), 1000Genomes rs56332208, ESP rs56332208, ExAC rs56332208, TOPMed rs56332208, REVEL 0.53, CADD 27.10, Benign
- R33Q (p.Arg33Gln), rs56332208, ClinGen CA142961, ClinVar RCV000041593, ClinVar RCV000883062, REVEL 0.29, CADD 24.70, Conflicting interpretations, not specified; not provided; Autosomal recessive nonsyndromic hearing loss 9
- R33W (p.Arg33Trp), rs150867836, ClinGen CA1564813, cosmic curated COSV10724, ClinVar RCV000385177, REVEL 0.55, CADD 31.00, Conflicting interpretations, Autosomal recessive nonsyndromic hearing loss 9; not provided
- V34A (p.Val34Ala), TOPMed rs1667108860
- V34I (p.Val34Ile), rs397517933, ClinGen CA142728, cosmic curated COSV10724, ClinVar RCV000041452, REVEL 0.17, CADD 15.60, Likely benign, not specified
- V34L (p.Val34Leu), TOPMed rs397517933, gnomAD rs397517933, REVEL 0.15, CADD 16.70, Likely benign
- L35P (p.Leu35Pro), gnomAD rs1425270742, REVEL 0.55, CADD 27.90
- E36D (p.Glu36Asp), NCI-TCGA Cosmic COSV5550, cosmic curated COSV55502, REVEL 0.23, CADD 23.30, Variant assessed as somatic; moderate impact.
- E36K (p.Glu36Lys), gnomAD rs1191109010, REVEL 0.34, CADD 26.00
- N37S (p.Asn37Ser), gnomAD rs1487782524, REVEL 0.28, CADD 22.90
- E39* (p.Glu39Ter), NCI-TCGA TCGA novel, CADD 43.00, Variant assessed as somatic; high impact.
- E39D (p.Glu39Asp), TOPMed rs1667108620, REVEL 0.41, CADD 13.00
- D40N (p.Asp40Asn), gnomAD rs1241872820, REVEL 0.40, CADD 22.70
- V41M (p.Val41Met), TOPMed rs1178898000, gnomAD rs1178898000, REVEL 0.15, CADD 21.30
- A42D (p.Ala42Asp), gnomAD rs763649380, REVEL 0.49, CADD 24.00
- A42G (p.Ala42Gly), gnomAD rs763649380, REVEL 0.21, CADD 25.30
- A42T (p.Ala42Thr), gnomAD rs868651321, REVEL 0.17, CADD 21.70
- A42V (p.Ala42Val), gnomAD rs763649380, REVEL 0.23, CADD 23.20
- D43N (p.Asp43Asn), gnomAD rs1318733938, REVEL 0.07, CADD 20.80
- D45A (p.Asp45Ala), gnomAD rs1361597258
- D45G (p.Asp45Gly), gnomAD rs1361597258, REVEL 0.23, CADD 19.90
- D45N (p.Asp45Asn), cosmic curated COSV10455, gnomAD rs1217004666, REVEL 0.11, CADD 15.00
- E46D (p.Glu46Asp), gnomAD rs1419930988, REVEL 0.53, CADD 35.00
- E46V (p.Glu46Val), gnomAD rs1284563346, REVEL 0.79, CADD 33.00
- T47I (p.Thr47Ile), rs1666849705, ClinGen CA346140019, ClinVar RCV003281451, Ensembl rs1666849705, REVEL 0.10, CADD 13.10, Uncertain significance, Inborn genetic diseases
- T47K (p.Thr47Lys), Ensembl rs1666849705, REVEL 0.34, CADD 13.80, Uncertain significance
- F48L (p.Phe48Leu), rs1444684344, ClinGen CA346140017, ClinVar RCV004504581, Ensembl rs1444684344, REVEL 0.67, CADD 24.90, Uncertain significance, Inborn genetic diseases
- R49L (p.Arg49Leu), cosmic curated COSV99718, ExAC rs111033444, TOPMed rs111033444, gnomAD rs111033444, REVEL 0.55, CADD 24.80, Uncertain significance
- R49Q (p.Arg49Gln), rs111033444, ClinGen CA142744, NCI-TCGA Cosmic COSV9971, ClinVar RCV000041461, REVEL 0.41, CADD 23.70, Uncertain significance, not specified; Autosomal recessive nonsyndromic hearing loss 9
- R49W (p.Arg49Trp), rs61746568, ClinGen CA142740, cosmic curated COSV10455, ClinVar RCV000041459, REVEL 0.70, CADD 28.70, Benign/Likely benign, not specified; not provided; Autosomal recessive nonsyndromic hearing loss 9
- W50* (p.Trp50Ter), rs202086317, ClinGen CA1564785, ClinVar RCV000778610, ClinVar RCV001008709, CADD 39.00, Pathogenic
- P51L (p.Pro51Leu), rs150132765, ClinGen CA1564784, ClinVar RCV000275983, ClinVar RCV001139472, REVEL 0.48, CADD 24.00, Conflicting interpretations, not provided; Autosomal recessive nonsyndromic hearing loss 9
- P51Q (p.Pro51Gln), ESP rs150132765, ExAC rs150132765, TOPMed rs150132765, gnomAD rs150132765, REVEL 0.38, CADD 22.80, Uncertain significance
- P51R (p.Pro51Arg), ESP rs150132765, ExAC rs150132765, TOPMed rs150132765, gnomAD rs150132765, Uncertain significance
- V52M (p.Val52Met), rs199992845, ClinGen CA177571, ClinVar RCV000151617, ClinVar RCV000185572, REVEL 0.29, CADD 22.60, Conflicting interpretations, Autosomal recessive nonsyndromic hearing loss 9; not specified; not provided
- A53S (p.Ala53Ser), 1000Genomes rs144915302, ExAC rs144915302, TOPMed rs144915302, gnomAD rs144915302, REVEL 0.07, CADD 17.40, Pathogenic
- A53T (p.Ala53Thr), rs144915302, ClinGen CA142750, cosmic curated COSV10455, ClinVar RCV000041464, REVEL 0.06, CADD 22.40, Benign/Likely benign, not provided; not specified
- A53V (p.Ala53Val), rs1879761, ClinGen CA142752, cosmic curated COSV55503, ClinVar RCV000021036, REVEL 0.11, CADD 22.90, Benign/Likely benign, not specified; not provided; Autosomal recessive nonsyndromic hearing loss 9
- S54R (p.Ser54Arg), TOPMed rs1446661227, gnomAD rs1446661227, REVEL 0.19, CADD 15.60
- S55G (p.Ser55Gly), ExAC rs749507265, gnomAD rs749507265, REVEL 0.11, CADD 18.50
- S55I (p.Ser55Ile), TOPMed rs768744355, REVEL 0.10, CADD 1.98
- S55N (p.Ser55Asn), TOPMed rs768744355
- S55R (p.Ser55Arg), ExAC rs749507265, gnomAD rs749507265, REVEL 0.11, CADD 18.10
- I56M (p.Ile56Met), 1000Genomes rs200185262, ExAC rs200185262, TOPMed rs200185262, gnomAD rs200185262, REVEL 0.33, CADD 11.90, Likely benign
- I56V (p.Ile56Val), gnomAD rs1666848086, REVEL 0.05, CADD 14.90
- D57N (p.Asp57Asn), rs754784459, ClinGen CA1564777, ClinVar RCV002166373, ExAC rs754784459, REVEL 0.15, CADD 16.20, Likely benign, not provided
- R58G (p.Arg58Gly), ExAC rs55758136, TOPMed rs55758136, gnomAD rs55758136, REVEL 0.10, CADD 19.80
- R58K (p.Arg58Lys), rs201067363, ClinGen CA1564775, NCI-TCGA Cosmic COSV9971, cosmic curated COSV99718, REVEL 0.05, CADD 13.90, Likely benign, not provided
- N59K (p.Asn59Lys), TOPMed rs1382647316, gnomAD rs1382647316, REVEL 0.23, CADD 15.60
- N59S (p.Asn59Ser), TOPMed rs1666847596
- E60G (p.Glu60Gly), ExAC rs757857070, gnomAD rs757857070, REVEL 0.73, CADD 28.00
- E60K (p.Glu60Lys), gnomAD rs1157591718, REVEL 0.67, CADD 26.40
- M61L (p.Met61Leu), ExAC rs764717002, TOPMed rs764717002, gnomAD rs764717002, REVEL 0.17, CADD 13.00
- M61V (p.Met61Val), ExAC rs764717002, TOPMed rs764717002, gnomAD rs764717002, REVEL 0.14, CADD 9.73
- L62P (p.Leu62Pro), rs761506005, ClinGen CA1564771, ClinVar RCV003827713, ExAC rs761506005, REVEL 0.84, CADD 26.90, Likely benign, not provided
- L62V (p.Leu62Val), NCI-TCGA Cosmic COSV9971, cosmic curated COSV99717, Variant assessed as somatic; moderate impact.
- E63K (p.Glu63Lys), rs753461913, ClinGen CA1564770, cosmic curated COSV55509, ClinVar RCV003367674, REVEL 0.48, CADD 23.40, Uncertain significance, Inborn genetic diseases
- E63Q (p.Glu63Gln), ExAC rs753461913, TOPMed rs753461913, gnomAD rs753461913, REVEL 0.28, CADD 22.90, Uncertain significance
- Q65R (p.Gln65Arg), Ensembl rs1666846950
- V66G (p.Val66Gly), Ensembl rs1572479736
- V66I (p.Val66Ile), TOPMed rs1572479737, REVEL 0.20, CADD 15.80
- N68S (p.Asn68Ser), gnomAD rs1216996626, REVEL 0.34, CADD 23.30
- K71E (p.Lys71Glu), rs2465385722, NCI-TCGA Cosmic COSV5549, cosmic curated COSV55496, ClinGen CA346139866, REVEL 0.50, CADD 27.60, Uncertain significance, not provided
- S74R (p.Ser74Arg), rs764474318, ClinGen CA1564768, ClinVar RCV001960809, ExAC rs764474318, REVEL 0.52, CADD 24.00, Conflicting interpretations, not provided
- N75D (p.Asn75Asp), ExAC rs761052683, gnomAD rs761052683, REVEL 0.32, CADD 24.00
- N75S (p.Asn75Ser), rs775875524, ClinGen CA1564766, cosmic curated COSV55499, ClinVar RCV000384261, REVEL 0.41, CADD 24.70, Uncertain significance, not specified; not provided
- K76* (p.Lys76Ter), rs772565732, ClinGen CA1564765, ClinVar RCV003700876, ExAC rs772565732, CADD 42.00, Pathogenic
- K76M (p.Lys76Met), ExAC rs759954218, gnomAD rs759954218, REVEL 0.47, CADD 28.90
- K76R (p.Lys76Arg), rs759954218, NCI-TCGA Cosmic COSV9971, cosmic curated COSV99716, ExAC rs759954218, REVEL 0.12, CADD 17.70, Variant assessed as somatic; moderate impact.
- L77F (p.Leu77Phe), rs368178451, ClinGen CA1564742, cosmic curated COSV55522, ClinVar RCV003230079, REVEL 0.15, CADD 22.80, Uncertain significance, not provided
- L77V (p.Leu77Val), ESP rs368178451, ExAC rs368178451, TOPMed rs368178451, gnomAD rs368178451, Uncertain significance
- I78T (p.Ile78Thr), ExAC rs771736008, gnomAD rs771736008, REVEL 0.67, CADD 23.70
- I78V (p.Ile78Val), TOPMed rs1192130440, gnomAD rs1192130440, REVEL 0.11, CADD 16.40
- G79R (p.Gly79Arg), rs727504911, ExAC rs727504911, TOPMed rs727504911, gnomAD rs727504911, REVEL 0.92, CADD 25.70, Uncertain significance, not provided
- T80I (p.Thr80Ile), gnomAD rs1258131104, REVEL 0.35, CADD 23.10
- F81L (p.Phe81Leu), ExAC rs753281507, TOPMed rs753281507, gnomAD rs753281507, REVEL 0.42, CADD 23.30
- R82C (p.Arg82Cys), rs13031859, ClinGen CA142803, cosmic curated COSV55494, ClinVar RCV000021048, REVEL 0.06, CADD 18.60, Likely benign, not specified; not provided; Autosomal recessive nonsyndromic hearing loss 9
- R82H (p.Arg82His), rs149766574, ClinGen CA142807, ClinVar RCV000041499, ClinVar RCV000767023, REVEL 0.23, CADD 23.30, Conflicting interpretations, Childhood onset hearing loss; not specified; not provided
- R82L (p.Arg82Leu), 1000Genomes rs149766574, ESP rs149766574, ExAC rs149766574, TOPMed rs149766574, REVEL 0.15, CADD 20.70, Benign
- M83I (p.Met83Ile), TOPMed rs1230221744, REVEL 0.27, CADD 23.70
- M83T (p.Met83Thr), rs752266635, ClinGen CA1564737, ClinVar RCV002642465, ClinVar RCV002642466, REVEL 0.69, CADD 25.20, Conflicting interpretations, not provided; Inborn genetic diseases
- V84A (p.Val84Ala), rs727505096, ClinGen CA185050, ClinVar RCV000156540, ClinVar RCV002515025, REVEL 0.40, CADD 26.40, Conflicting interpretations, not provided; not specified
- Q86H (p.Gln86His), gnomAD rs1317660474, REVEL 0.32, CADD 25.00
- K87N (p.Lys87Asn), cosmic curated COSV55506, 1000Genomes rs545159141, ExAC rs545159141, gnomAD rs545159141, REVEL 0.15, CADD 22.90
- K87R (p.Lys87Arg), Ensembl rs1666609430, REVEL 0.10, CADD 22.60
- V88A (p.Val88Ala), rs752133527, ClinGen CA1564734, NCI-TCGA Cosmic COSV5550, cosmic curated COSV55504, REVEL 0.43, CADD 24.30, Uncertain significance, Inborn genetic diseases
- V88M (p.Val88Met), 1000Genomes rs199766309, ExAC rs199766309, gnomAD rs199766309, REVEL 0.34, CADD 25.10
- V89A (p.Val89Ala), ExAC rs766934718, TOPMed rs766934718, gnomAD rs766934718
- V89E (p.Val89Glu), ExAC rs766934718, TOPMed rs766934718, gnomAD rs766934718, REVEL 0.48, CADD 24.00
- V89I (p.Val89Ile), gnomAD rs1449106051, REVEL 0.09, CADD 19.90
- E91K (p.Glu91Lys), TOPMed rs1238562287, gnomAD rs1238562287, REVEL 0.15, CADD 22.50
- S92R (p.Ser92Arg), TOPMed rs1005043242, gnomAD rs1005043242, REVEL 0.05, CADD 14.40
- H93L (p.His93Leu), gnomAD rs1458638479, REVEL 0.13, CADD 13.60
- H93Y (p.His93Tyr), Ensembl rs2148102505, REVEL 0.15, CADD 13.30
- V94G (p.Val94Gly), ExAC rs773490121, TOPMed rs773490121, gnomAD rs773490121, REVEL 0.48, CADD 25.80
- V94M (p.Val94Met), TOPMed rs1194603156, gnomAD rs1194603156, REVEL 0.06, CADD 22.30
- E95Q (p.Glu95Gln), TOPMed rs1666608591, gnomAD rs1666608591, REVEL 0.21, CADD 19.80
- V96A (p.Val96Ala), TOPMed rs1666608394
- V96M (p.Val96Met), gnomAD rs1238722201, REVEL 0.12, CADD 22.90
- D98E (p.Asp98Glu), ExAC rs762137392, TOPMed rs762137392, gnomAD rs762137392, REVEL 0.10, CADD 15.80
- D98G (p.Asp98Gly), ESP rs143766273, ExAC rs143766273, TOPMed rs143766273, gnomAD rs143766273, REVEL 0.49, CADD 26.40
- D98N (p.Asp98Asn), Ensembl rs2148102467, REVEL 0.28, CADD 25.30
- T99M (p.Thr99Met), rs555829802, ClinGen CA1564728, cosmic curated COSV55498, ClinVar RCV003338289, REVEL 0.17, CADD 23.30, Conflicting interpretations, Inborn genetic diseases; not provided
- I101T (p.Ile101Thr), rs754508360, ClinGen CA1564727, ClinVar RCV001847384, ExAC rs754508360, REVEL 0.19, CADD 22.70, Conflicting interpretations, not provided
- D102V (p.Asp102Val), ExAC rs774280018, TOPMed rs774280018, gnomAD rs774280018, REVEL 0.78, CADD 29.30, Uncertain significance, Inborn genetic diseases
- D103E (p.Asp103Glu), TOPMed rs1310656089, gnomAD rs1310656089, REVEL 0.12, CADD 20.30
- D103G (p.Asp103Gly), gnomAD rs1359275167, REVEL 0.25, CADD 23.40
- N104S (p.Asn104Ser), Ensembl rs1346253976
- N105S (p.Asn105Ser), 1000Genomes rs201023798, ExAC rs201023798, gnomAD rs201023798, REVEL 0.27, CADD 25.80
- A106G (p.Ala106Gly), ExAC rs777389771, TOPMed rs777389771, gnomAD rs777389771, REVEL 0.08, CADD 23.10
- A106V (p.Ala106Val), ExAC rs777389771, TOPMed rs777389771, gnomAD rs777389771, REVEL 0.11, CADD 23.10
- I107V (p.Ile107Val), TOPMed rs1666607376, gnomAD rs1666607376, REVEL 0.08, CADD 1.04
- I108F (p.Ile108Phe), ExAC rs727505189, TOPMed rs727505189, gnomAD rs727505189, Likely benign
- I108V (p.Ile108Val), rs727505189, ClinGen CA185331, ClinVar RCV000156679, ClinVar RCV003546484, REVEL 0.10, CADD 17.30, Conflicting interpretations, Inborn genetic diseases; not specified; not provided
- K109M (p.Lys109Met), ExAC rs747863126, TOPMed rs747863126, gnomAD rs747863126, REVEL 0.14, CADD 25.40
- T110P (p.Thr110Pro), Ensembl rs1572469109
- S111I (p.Ser111Ile), TOPMed rs1666533513
- S111R (p.Ser111Arg), rs2148098670, ClinGen CA346139582, ClinVar RCV002045147, Ensembl rs2148098670, REVEL 0.28, CADD 16.10, Uncertain significance, not provided
- C113* (p.Cys113Ter), cosmic curated COSV99719, 1000Genomes rs139098225, ESP rs139098225, ExAC rs139098225, CADD 34.00, Uncertain significance
- C113R (p.Cys113Arg), rs146615166, ClinGen CA177569, ClinVar RCV000151616, ClinVar RCV002516046, REVEL 0.20, CADD 14.90, Conflicting interpretations, Inborn genetic diseases; not specified; not provided
- V114L (p.Val114Leu), 1000Genomes rs376117319, ESP rs376117319, ExAC rs376117319, TOPMed rs376117319, REVEL 0.04, CADD 4.56, Benign
- V114M (p.Val114Met), rs376117319, ClinGen CA1564693, ClinVar RCV002884119, ClinVar RCV003730300, REVEL 0.06, CADD 11.60, Conflicting interpretations, not provided; Inborn genetic diseases
- V116I (p.Val116Ile), rs1666532895, ClinGen CA346139556, ClinVar RCV002743285, Ensembl rs1666532895, AlphaMissense 0.06, MetaLR 0.10, Uncertain significance, Inborn genetic diseases
- R117G (p.Arg117Gly), ExAC rs773214630, TOPMed rs773214630, gnomAD rs773214630, REVEL 0.23, CADD 22.80
- R117P (p.Arg117Pro), TOPMed rs1403233423, gnomAD rs1403233423
- R117Q (p.Arg117Gln), cosmic curated COSV55510, TOPMed rs1403233423, gnomAD rs1403233423, REVEL 0.12, CADD 13.70
- R117W (p.Arg117Trp), ExAC rs773214630, TOPMed rs773214630, gnomAD rs773214630, REVEL 0.42, CADD 25.00
- Y118* (p.Tyr118Ter), rs2465353501, ClinGen CA346139541, ClinVar RCV003548618, Pathogenic
- Y118C (p.Tyr118Cys), ExAC rs761804786, TOPMed rs761804786, gnomAD rs761804786, REVEL 0.82, CADD 25.00
- Y118F (p.Tyr118Phe), ExAC rs761804786, TOPMed rs761804786, gnomAD rs761804786, REVEL 0.54, CADD 23.70
- Y118H (p.Tyr118His), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- A120T (p.Ala120Thr), gnomAD rs1421216292, REVEL 0.11, CADD 13.50
Public OTOF analysis runs
- OTOF analysis run — OTOF (2,968 variants) — completed 2026-08-18